Advanced search
Publication Cover
HIV Clinical Trials Volume 8, 2007 - Issue 3
Submit an article Journal homepage
55
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Safety and Tolerability of Sequential Pegylated IFN-α2a and Tenofovir for Hepatitis B Infection in HIV+ Individuals

R.M. JohnsonIndiana University School of Medicine, Indianapolis, IndianaCorrespondence[email protected]
,
M.B. RistigWashington University School of Medicine, St. Louis, Missouri
,
E.T. OvertonWashington University School of Medicine, St. Louis, Missouri
,
M. Lisker-MelmanWashington University School of Medicine, St. Louis, Missouri
,
O.W. CummingsIndiana University School of Medicine, Indianapolis, Indiana
&
J.A. AbergNew York University, New York, New York, USA
Pages 173-181 | Published online: 06 Jan 2015

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

MariaCássia Mendes-Corrêa & Marina Núñez. (2010) Management of HIV and hepatitis virus coinfection. Expert Opinion on Pharmacotherapy 11:15, pages 2497-2516.
Read now
Erik De Clercq. (2008) Emerging antiviral drugs. Expert Opinion on Emerging Drugs 13:3, pages 393-416.
Read now

Articles from other publishers (13)

Sagarika Shahriar, Yusha Araf, Rasel Ahmad, Pravakar Kattel, Ganga Sagar Sah, Tanjim Ishraq Rahaman, Rahila Zannat Sadiea, Shahnaj Sultana, Md. Sayeedul Islam, Chunfu Zheng & Md. Golzar Hossain. (2022) Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment. Frontiers in Microbiology 12.
Crossref
A. M. Ortega-Prieto, J. K. Skelton, S. N. Wai, E. Large, M. Lussignol, G. Vizcay-Barrena, D. Hughes, R. A. Fleck, M. Thursz, M. T. Catanese & M. Dorner. (2018) 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nature Communications 9:1.
Crossref
Patrick Miailhes, Marianne Maynard-Muet, Fanny Lebossé, Fabrice Carrat, Cécile Bouix, Caroline Lascoux-Combe, Philippe Sogni, David Rey, Yoann Barthe, Stanislas Pol, Patrice Cacoub, Fabien Zoulim & Lionel Piroth. (2014) Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study. Journal of Hepatology 61:4, pages 761-769.
Crossref
Hsin-Yun Sun. (2014) Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review. World Journal of Gastroenterology 20:40, pages 14598.
Crossref
Donald J. AbrahamAntonin Holý & Erik De Clercq. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 219 256 .
R. Pais & Y. Benhamou. (2010) Traitements à long terme de l’hépatite chronique B chez le patient co-infecté par le VIH. Gastroentérologie Clinique et Biologique 34, pages S136-S141.
Crossref
G Brook, J Main, M Nelson, S Bhagani, E Wilkins, C Leen, M Fisher, Y Gilleece, R Gilson, A Freedman, R Kulasegaram, K Agarwal, C Sabin & C Deacon‐Adams. (2009) British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010. HIV Medicine 11:1, pages 1-30.
Crossref
K. Lacombe, J. Bottero, M. Lemoine, A. Boyd & P. M. Girard. (2009) HIV/hepatitis B virus co-infection: current challenges and new strategies. Journal of Antimicrobial Chemotherapy 65:1, pages 10-17.
Crossref
MARK S. SULKOWSKI. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 1737 1744 .
Chloe L. Thio. (2009) Hepatitis B and human immunodeficiency virus coinfection. Hepatology 49:S5, pages S138-S145.
Crossref
David M Iser & Joseph J Sasadeusz. (2008) Current treatment of HIV/hepatitis B virus coinfection. Journal of Gastroenterology and Hepatology 23:5, pages 699-706.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:3.
Crossref
Mark S. Sulkowski. (2008) Viral hepatitis and HIV coinfection. Journal of Hepatology 48:2, pages 353-367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.